16:0/18:1, PEth 16:0/18:2, and PEth 18:1/18:1.
7-11 The distribution of different PEths in human blood shows inter-and intra-individual variations, and alcohol habits and other factors such as a person`s diet and diseases might influence the distribution of PEth homologues. 12 , 13 Nalesso et al 10 identified 17 different PEths in blood from alcohol-dependent subjects, whereas only PEth 16:0/18:1 and PEth 16:0/18:2 were found in blood from social drinkers. The average half-life of PEth is approximately 3-5 days for heavy drinkers and 10-12 days for persons with no or low alcohol consumption. 14, 15 A blood concentration of PEth ≥211 ng/mL (300 nmol/L) indicates alcohol abuse, whereas a PEth concentrations ≤21 ng/mL (≤30 nmol/L) indicate low alcohol consumption.
14 LC-MS/MS is commonly used for PEth analysis due to high sensitivity and due to the possibility to distinguish between the different PEth homologues. 6, 8, 13, 16 A review published in 2016 by Oppolzer et al 16 shows that most LC-MS/MS methods used for the determination of PEths in blood employ sample preparation by liquid-liquid extraction (LLE) using 2-propanol and hexane as organic solvents.
Aradottir and Olsson 17 reported PEth recovery to be 25% higher when 2-propanol was added before hexane compared to when a mixture of the two compounds was added, probably due to the phospholipids from the cell membranes becoming more available after the lipid-protein linkages are broken by adding 2-propanol.
Protein precipitation (PPT) and solid phase extraction (SPE) have also been used for sample preparation of PEths from biological samples. 10, 18, 19 Recently, Andreassen et al 20 described a high throughput UHPLC-MS/MS method for determination of PEth 16:0/18:1 in whole blood using 96-well PPT with 2-propanol as organic solvent.
Supported liquid extraction (SLE) is another technique that that is
fast and easy which can be used for isolation of different compounds from biological samples, and a technique that often generates
cleaner extracts than what is obtained by PPT. [21] [22] [23] [24] [25] [26] [27] By 96-well SLE, the sample preparation time and the need for manual interventions can be significantly reduced compared to single vial LLE, SPE, SLE, and PPT. [28] [29] [30] [31] For laboratories doing large volume PEth analyses, a method combining a high throughput sample preparation by 96-well SLE with a sensitive and selective determination by UHPLC-MS/MS can be of great interest.
To the best of our knowledge, we present the first UHPLC-MS/ MS method for the determination of PEth in whole blood using SLE for sample preparation. Different organic mixtures of MTBE/2- 
| MATERIAL S AND ME THODS

| Chemicals and materials
| Whole blood samples
Human whole blood samples from hospital patients with somatic illness participating in a research study were collected to determine PEth 16:0/18:1 concentrations. The samples were received in 5 mL BD Vacutainer ® Plus glass blood collection tubes containing 10 mg sodium fluoride and 8 mg potassium oxalate from BD (Franklin Lake, NJ, USA). An amount of 100 μL blood was transferred to 5 mL polypropylene tubes from Sarstedt AG (Rommelsdorf, Germany) and stored at 4°C before analysis. Blank whole blood obtained from non-alcohol drinkers or PEth negative whole blood samples were used when the method was validated.
The blank blood from non-alcohol drinkers were collected in the same collection tubes as the samples from the hospital patients with somatic illness. An exception was the recovery test, which was investigated using whole blood containing 2 g sodium fluoride, 6 mL heparin and 10 mL water per 450 mL blood obtained from the Blood Bank at Ullevaal Oslo University Hospital (Oslo, Norway). 
| Preparation of calibrators, quality control samples, and internal standards
| Sample preparation
Calibrator and QC samples were prepared by first adding 100 μL whole blood and 100 from Agilent Technologies, Santa Clara, CA, USA). Table 1 shows the analyte and internal standard MRM transitions, fragmentation ion voltages, collision energies, and dwell times.
| Method validation
The method validation was performed using whole blood as matrix and included: calibration curves, inter-assay precision and accuracy, limit of detection (LOD), limit of quantification (LOQ), recovery, matrix effects (ME), carry-over, and stability. There are many guidelines and recommendations for validation of analytical methods that are published. [33] [34] [35] [36] [37] [38] [39] The validation of the method in this study is based on 
| RE SULTS AND D ISCUSS I ON
The aim of the present study was to develop and validate a rapid, sensitive, accurate, precise, and robust UHPLC-MS/MS method for determination of PEth 16:0/18:1 in whole blood.
| Optimization of sample preparation
It can be difficult to obtain clean extracts when PEths are prepared from whole blood as PEths are phospholipids and therefore difficult to isolate from other phospholipids. At first, we tested PPT with 2-propanol and then LLE using an organic solvent mixture of hexane/2-propanol, heptane/2-propanol, or MTBE/2-propanol, all 
| UHPLC-MS/MS analysis
| Matrix matching of calibrators and QC samples
The scientific working group for forensic toxicology (SWGTOX) 42 recommends that calibrators and QC samples are matrix matched.
In this study, whole blood was used as matrix for calibrators and QC samples when the method was validated. However, as PEthfree blood can be difficult to obtain, part of the method was also validated using Type 1 water as surrogate matrix for calibrators and QC samples (see Table S1 ). Hewavitharana have previously shown that a co-eluting isotope labeled internal standard can eliminate the need for matrix matching. 43 The recent review published in 2016 by Thakare et al 36 shows there are a lot of different solvents that are used as surrogate matrixes. In an experiment comparing the use of blank blood and Type 1 water as matrix for standard samples, we observed that peak response ratios of analyte/ internal standard were independent of the matrix (Table 3 ). This indicates that matrix matching may not be necessary. However, if samples studied have a higher concentration than the upper LOQ, dilution of the samples before analysis is required. In such cases, matrix matching is usually necessary as dilution effects may not be tracked by the internal standard that is added after the dilution. As shown in Table 3 , also the influence of addition order standard working solution) was tested. The addition order had great impact on the PEth peak responses, but peak response ratio (analyte/internal standard) were not affected ( Table 3 ). The low peak responses for the blood samples added working solutions was used as internal standard in this study. from the expected ion ratio value.
| Method validation
| Calibration curves
| Precision and accuracy
Intermediate precision and accuracy were determined from the cal- Table 4 .
| LOD and LOQ
Limit of detection and LOQ were determined from Equations 1 and 2, respectively, and based on data from the same QC samples that were analyzed to determine intermediate accuracy and precision. To avoid unrealistic low values, the standard deviation of a QC sample with low analyte concentration was used instead of using the standard deviation of a blank sample for the calculations, as described by
Armbruster et al. 48, 49 Additional requests for LOD and LOQ were that the S/N values of both MRM transitions needed to be ≥3 and ≥10, respectively, and that for LOQ the inter-assay precision and accuracy values (Table 4 ) both were ≤20%.
(1) LOD = 3.3 × standard deviation of QC 1.4ng∕mL + Blank mean concentration TA B L E 3 Influence of addition order during sample preparation and a comparison between using whole blood as matrix and Type 1 water as surrogate matrix for standard samples 
| Matrix effects
ME were investigated at three concentration levels according to the procedure described by Matuszewski et al. 50 Two sets of samples ME were calculated by Equation 3. ME = 100 indicates that there were no ME, whereas ME >100 indicates possible matrix enhancement and ME <100 indicates possible matrix suppression. Minor ion suppression effects were observed; however, the co-eluting isotope labeled internal standard corrected for these effects (Table 4) .
| Recovery
Recovery was studied by spiking PEth 16:0/18:1 to human blood samples before sample preparation (n = 4 per level) and after sample preparation (n = 4 per level). In both cases, the internal standard was to be approximately 50% (Table 4) . A recovery of 50% was considered enough as the internal standard PEth 16:0/18:1 is expected to correct for recovery variations and possible ion suppression/enhancement effects.
| Carry-over
Carry-over was investigated by injecting an extracted standard sample with a PEth 16:0/18:1 concentration of 2114 ng/mL (3007 nmol/L) and then three subsequent injections of extracted blank samples. Average carry-over was 0.03% in the first blank samples (n = 4) and 0.01% in the second blank samples (n = 4) and 0.00% in the third blank samples (2) LOQ =10 × standard deviation of QC 1.4ng∕mL +Blank mean concentration
TA B L E 4 Inter-assay accuracy and precision, recovery, and matrix effects 
| Stability
In previous stability studies, Helander were analyzed regarding the comparison of concentrations with ref- 
| Comparison with a reference laboratory
For comparison with reference laboratories, five unknown blood samples were analyzed in our laboratory by the developed method and by two other laboratories that were using other sample preparation procedures and a different setup for their LC-MS/MS analyses.
Calculated concentrations obtained by reference laboratory 1 and 2
were within 18%-31% and 3%-33%, respectively, compared to the concentrations obtained in our laboratory by the developed method (Table 5 ).
| Application of the method
The developed method will be used in a research project to determine PEth 16:0/18:1 in more than 2500 human whole blood samples from hospital patients with somatic illness.
| CON CLUS IONS
A rapid and sensitive UHPLC-MS/MS method for determination of PEth 16:0/18:1 in whole blood was developed and fully validated.
For the first time, 96-well SLE was used for the sample preparation of PEth in whole blood.. Based on evaluation of recovery, purity of extracts and evaporation time, a mixture of MTBE/2-propanol (5:1, v:v) was chosen as organic eluent for the 96-well SLE. The method was validated using whole blood as matrix. However, we found peak response ratios (analyte/internal standard) to be the same in standard samples prepared in Type 1 water as the ratios for standard samples prepared in whole blood, indicating that matrix matching may not be necessary. The method can be used for high throughput analysis and sensitive determinations of PEth 16:0/18:1 in whole blood, which can be important in clinical practice and epidemiological studies related to alcohol use. 
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